International research indicates giving infants nirsevimab would cause sharp drop in rates of respiratory syncytial virus infection
A vaccine could reduce by 80% the numbers of babies and young children admitted to hospital with respiratory syncytial virus (RSV), a “groundbreaking” study has found.
The study, published in the peer-reviewed New England Journal of Medicine, involved 8,058 healthy babies aged up to 12 months from the UK, France and Germany, who were approaching their first RSV season.
About Author
More Stories
Newborns treated with antibiotics respond less well to vaccines, study shows
As a geneticist, I will not mourn 23andMe and its jumble of useless health information | Adam Rutherford
The best walking pads and under-desk treadmills, tried and tested to turn your workday into a workout